# Çharles N. Bernstein

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-n-bernstein/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,996 |
| Field | Inflammatory Bowel Disease |
| h-index | 122 |
| i10-index | 607 |
| Last Known Institution | Research Manitoba |
| OpenAlex ID | https://openalex.org/A5017585326 |
| ORCID iD | https://orcid.org/0000-0001-8041-3574 |
| Works | 1,355 |

## Researcher papers

- [Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology](https://scholariq.org/papers/toward-an-integrated-clinical-molecular-and-serological-classification-of/)
- [Environmental triggers in IBD: a review of progress and evidence](https://scholariq.org/papers/environmental-triggers-in-ibd-a-review-of-progress-and-evidence/)
- [Clinical Practice Guidelines for the Use of Video Capsule Endoscopy](https://scholariq.org/papers/clinical-practice-guidelines-for-the-use-of-video-capsule-endoscopy/)
- [Global evolution of inflammatory bowel disease across epidemiologic stages](https://scholariq.org/papers/global-evolution-of-inflammatory-bowel-disease-across-epidemiologic-stages/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis](https://scholariq.org/papers/patient-health-questionnaire-9-scores-do-not-accurately-estimate-depression/)
- [Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting](https://scholariq.org/papers/management-of-patients-with-crohn-s-disease-and-ulcerative-colitis-during-the/)
- [Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease](https://scholariq.org/papers/teduglutide-a-novel-mucosally-active-analog-of-glucagon-like-peptide-2-glp-2-for/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Gut microbiota and health](https://scholariq.org/topics/gut-microbiota-and-health/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Research Manitoba](https://scholariq.org/institutions/research-manitoba/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.